Neonode - Lower Burn Rate and Positiveness in the Lawsuit
2022-11-11 17:32:00
Redeye states that Q3 came in below estimates on sales but that reasonable cost control and a strong USD contributed to a lower-than-expected burn rate. The lawsuit has shown promising development and is now awaiting written decisions in the IPR processes in the next couple of months. Redeye lowers its estimates on both sales and costs, resulting in lowering its valuation range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/